These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 15961927

  • 1. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease.
    Alnaqdy A, Al-Maskari M.
    Med Princ Pract; 2005; 14(4):209-12. PubMed ID: 15961927
    [Abstract] [Full Text] [Related]

  • 2. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K, Murayama H, Uzu T, Togashi K, Olivo PD, Kahaly GJ.
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y, Li C, Takagi J, Gotoh M, Habu S, Yasaka-Nomura T, Ishihara R, Nakasone Y, Nakamura R, Morikawa R, Otake K, Nogimori T, Ishizuki Y.
    Int J Clin Pharmacol Res; 2004 Dec; 24(4):111-6. PubMed ID: 15754915
    [Abstract] [Full Text] [Related]

  • 11. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
    Liu C, Hermsen D, Domberg J, Graeber C, Hautzel H, Duan Y, Xu KF, Liu CP, Mao XD, Cupisti K, Scherbaum WA, Schott M.
    Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673
    [Abstract] [Full Text] [Related]

  • 12. Limited usefulness of antithyroperoxidase and antithyroglobulin assays in Jamaicans with Graves' disease.
    Wright-Pascoe R, Smikle MF, Barton EN, James OB.
    Hum Antibodies; 1999 Jul; 9(3):161-4. PubMed ID: 10690629
    [Abstract] [Full Text] [Related]

  • 13. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 14. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM, Liu W, Lu GH.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):940-2. PubMed ID: 12899792
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of immunological tests in thyroid diseases].
    Hirooka Y, Mitsuma T.
    Rinsho Byori; 1991 Sep 10; 39(9):920-5. PubMed ID: 1942565
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.